Search results
2 days ago · Genentech USA (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including oncology, immunology, ophthalmology, metabolism, neurology, and infectious disease, among others.
3 days ago · 8 equities research analysts have issued 1 year price targets for Roche's stock. Their RHHBY share price targets range from $40.00 to $40.00. On average, they anticipate the company's share price to reach $40.00 in the next year. This suggests a possible upside of 17.3% from the stock's current price. View analysts price targets for RHHBY or ...
2 days ago · About Genentech. Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and ...
1 day ago · Genentech, a member of the Roche Group announced today the U.S. Food and Drug Administration has approved the Vabysmo ® 6.0 mg single-dose prefilled syringe for use in the treatment of wet, or ...
2 days ago · About Art Levinson. Art Levinson has been chairman of the board of Apple since 2011; he owns more shares of Apple than CEO Tim Cook. He was the CEO of successful biotech firm Genentech from 1995 ...
5 days ago · The latest GENETEC stock prices, stock quotes, news, and history to help you invest and trade smarter.
2 days ago · Genentech USA (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including oncology, immunology, ophthalmology, metabolism, neurology, and infectious disease, among others.
